Długoterminowa obserwacja hipoplazji pontocerebellum typu 2A: przeżywalność, przebieg objawów i obciążenie chorobą
Long-term follow-up in pontocerebellar hypoplasia type 2A: survival, symptom course, and disease burden
W skrócie
[Preprint - wstępne wyniki] Badanie obejmowało 65 pacjentów z rzadką chorobą genetyczną (hipoplazja pontocerebellum typu 2A), u której obserwowano znaczne trudności w karmieniu, zaburzenia ruchu i napady padaczki. Wykazano, że 10-letnia przeżywalność wyniosła 71,5%, przy czym napady padaczki nasiliały się z wiekiem, a niektóre objawy jak wymioty ulegały poprawie. Wbrew oczekiwaniom, uczucie obciążenia chorobą u rodziców malało wraz z wiekiem dziecka, a największy problem stanowiła niepokojność, a nie samo epilepsja.
Oryginalny abstract (angielski)
Background: Pontocerebellar hypoplasia Type 2A (PCH2A) is a rare, autosomal recessive disorder with reduced life expectancy. Clinical features include profound developmental delay, microcephaly, and a dyskinetic movement disorder. Additional symptoms frequently observed are feeding difficulties, vomiting, dystonic attacks, and seizures. Compared to parents of typically developing children, parents of children with PCH2A experience decreased health-related quality of life. The aim of this study was to provide a follow-up on survival, symptoms, and perceived disease burden. Methods Patients were primarily recruited via the German patients' organization (PCH-Familie e.V.). Inclusion required genetic confirmation of PCH2A. Data were collected from 2020-2022 using parent questionnaires and medical reports; uncertainties were clarified during semi-standardized telephone interviews. Statistical analysis was quantitative, appropriate statistical tests were used, depending on the data distribution. Results Sixty-five patients participated, with a median age of 6.4 years and balanced gender distribution. Sixteen patients (25%) died at a median age of 5.5 years. Ten-year survival rate was 71.5%. Feeding difficulties, dyskinesia, and sleep disturbances were common and persistent symptoms. Seizures increased with age, whereas vomiting and dystonic attacks decreased over time. Perceived disease burden differed among families, but most reported overall impaired quality of life. The most burdensome symptoms were restlessness, sleep disorder, and gastrointestinal issues, while seizures/epilepsy were ranked as least impactful. With increasing age, perceived burden from feeding and swallowing disorders, gastrointestinal problems, episodic abdominal pain, and overall quality of life decreased significantly. Conclusions Life expectancy in PCH2A remains limited, but survival appears to have improved in more recent birth cohorts. Most symptoms persist with age, though a few, like reflux and dystonic attacks, improve in tendency. Conversely, respiratory symptoms and seizures tend to worsen. Notably, perceived disease burden generally decreases as patients age. Restlessness proved to be the most burdensome symptom, although it has not been clearly described before.